Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette P Conley

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Cancer Medicine|July 25, 2025
A Data-Driven Epigenetic Characterization of Morning Fatigue Severity in Oncology Patients Receiving Chemotherapy: Associations With Epigenetic Age Acceleration, Blood Cell Types, and Expression-Associated MethylationCaroline Le, Maureen Lewis, Carolyn S Harris, et al.
Annals of Neurology|November 14, 2025
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain InjuryMargaux E Miller, Benjamin E Zusman, Chia-Ling Phuah, et al.
International Journal of Nursing Sciences|February 27, 2020
Precision health: A nursing perspectiveMei R Fu, Emma Kurnat-Thoma, Angela Starkweather, et al.
Nursing Outlook|March 22, 2020
Use of individual development plans for nurse scientist trainingHilaire J Thompson, Sheila Judge Santacroce, Rita H Pickler, et al.
Human Molecular Genetics|July 1, 2005
Meta-analysis of genome scans of age-related macular degenerationSheila A Fisher, Goncalo R Abecasis, Beverly M Yashar, et al.
Journal of Neurotrauma|December 7, 2018
Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh VisionPatrick M Kochanek, Travis C Jackson, Ruchira M Jha, et al.
Journal of the National Cancer Institute|September 9, 2024
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairmentMichelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, et al.
International Journal of Epidemiology|January 19, 2012
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtypeReecha Sofat, Juan P Casas, Andrew R Webster, et al.
Nature Genetics|September 17, 2013
Identification of a rare coding variant in complement 3 associated with age-related macular degenerationXiaowei Zhan, David E Larson, Chaolong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationWei Chen, Dwight Stambolian, Albert O Edwards, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Cancer Medicine|July 25, 2025
A Data-Driven Epigenetic Characterization of Morning Fatigue Severity in Oncology Patients Receiving Chemotherapy: Associations With Epigenetic Age Acceleration, Blood Cell Types, and Expression-Associated MethylationCaroline Le, Maureen Lewis, Carolyn S Harris, et al.
Annals of Neurology|November 14, 2025
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain InjuryMargaux E Miller, Benjamin E Zusman, Chia-Ling Phuah, et al.
International Journal of Nursing Sciences|February 27, 2020
Precision health: A nursing perspectiveMei R Fu, Emma Kurnat-Thoma, Angela Starkweather, et al.
Nursing Outlook|March 22, 2020
Use of individual development plans for nurse scientist trainingHilaire J Thompson, Sheila Judge Santacroce, Rita H Pickler, et al.
Human Molecular Genetics|July 1, 2005
Meta-analysis of genome scans of age-related macular degenerationSheila A Fisher, Goncalo R Abecasis, Beverly M Yashar, et al.
Journal of Neurotrauma|December 7, 2018
Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh VisionPatrick M Kochanek, Travis C Jackson, Ruchira M Jha, et al.
Journal of the National Cancer Institute|September 9, 2024
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairmentMichelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, et al.
International Journal of Epidemiology|January 19, 2012
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtypeReecha Sofat, Juan P Casas, Andrew R Webster, et al.
Nature Genetics|September 17, 2013
Identification of a rare coding variant in complement 3 associated with age-related macular degenerationXiaowei Zhan, David E Larson, Chaolong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationWei Chen, Dwight Stambolian, Albert O Edwards, et al.
Pageof 36